Page 351 - Glucose Monitoring Devices
P. 351

358    Index




                         Closed-loop insulin delivery system (Continued)  observational trials, 140e141
                           continuous subcutaneous insulin infusion (CSII)  operational advantage, 138
                              pumps, 328                     pregnancy data, 142e143
                           controlled research environments, 334e335  quality of life data, 143
                           FDA approved simulator, 334       randomized controlled trials, 140e142,
                           free-living home assessments, 335    146te147t
                           fully closed-loop (FCL) system, 334  real-time CGM (RT-CGM), 140e142
                           hybrid closed-loop systems, 334   retrospective, 140
                           MiniMed 670G system               Senseonics, 150
                            adjunctive agents, 339           sensor-augmented pump (SAP), 151e152
                            auto mode, 337e338              Continuous glucose monitoring (CGM) system,
                            bihormonal systems, 339             20e21, 53, 275. See also Minimally
                            challenges, 339e340                 invasive continuous glucose monitoring
                            forced system, 338                  (CGM) sensor calibration
                            Guardian sensor 3, 336e337       advances, 111
                            hotel-based study, 335e336       automated closed-loop control, 159
                            hybrid closed-loop systems, 339e340  blood glucose (BG) fluctuations, 241e242
                            insulin pump, 337                calibration errors, 241e242
                            3-month single-arm study, 336    challenges, 241
                            Nightscout Project, 340e346      clinical accuracy
                            outpatient studies, 335e336        CGM data point represention, 161f
                            patient considerations, 346        continuous glucose-error grid analysis
                            pediatric population, 336           (CG-EGA), 161e162
                            research unit-based study, 335     euglycemia, 164e165
                            retrospective analysis, 338        hyperglycemia, 164e165
                           predictive low glucose suspend (PLGS) system,  hypoglycemia, 164e165
                              331e332                          point accuracy-error grid analysis (P-EGA),
                           primary control algorithms, 333      161e162, 162f
                           registry data, 328                  rate-error grid analysis (R-EGA), 163e164,
                           transitional environments, 335       164f
                         Consensus error grid (CEG), 35, 45e46, 46f  commercial systems
                         Continuous glucose-error grid analysis  Abbott Freestyle Libre flash glucose monitor,
                              (CG-EGA), 161e162                 127
                         Continuous glucose monitoring (CGM) device  Dexcom G6 CGM, 127e128
                           alarm feature, 139                  Eversense CGM System, 128e129
                           clinical application, 139           feature comparison chart, 129f
                           Dexcom G6 Mobile system, 145e149    implantable sensors, 126e127
                           efficacy, 140e143                    Medtronic Guardian Connect, 128
                           evolution, 136                      transcutaneous sensor-based systems, 126
                           flash glucose monitoring system    disposable sensor, 111
                            Freestyle Librelink App, 150e151  error mitigation, 241e242
                            HART CGM study, 151              glucose transduction technologies
                            IMPACT trial, 150e151              electrochemical glucose oxidase sensor, 116
                           glycemic control, 138               enzymatic, electrochemical-based glucose
                           glycemic load, 138                   sensors, 113e115
                           inpatient, 152                      fluorescent glucose sensors, 117
                           limitations                         microneedle-array sensors, 116e117
                            device dependent, 144e145          nonenzymatic, optical-based sensors, 114e115
                            healthcare provider dependent, 144  tissue-integrating sensors, 117
                            user dependent, 143e144          glycemic variability, 111
                           Medtronic, 149                    interstitial glucose (IG) fluctuations, 159e160
                           Medtrum, 149                      measurement error modeling
   346   347   348   349   350   351   352   353   354   355   356